US Skin Care Actives Formulation Patents Granted in 2007

Thank you for visiting FormulaScan . Please click on the Patent No to study the full patent document

US PATENTS IN SKIN CARE ACTIVES GRANTED IN 2007



Patent No.: US7157097B2  Issued: 02/Jan/2007

Title: Penetration enhancing and irritation reducing systems

Applicant/Assignee: CELLEGY PHARMACEUTICALS INC

Application No.: 10/389715   Filing Date: 12/Mar/2003

Abstract:

This invention lies in the technology of transdermal and topical drug delivery. In particular, the present invention relates to enhancement of the penetration of transdermally or topically applied drugs and with the reduction of skin irritation that often accompanies transdermal and topical drug delivery.

Priority: US2001-963287 Applic. Date: 2001-09-24; US1998-189090 Applic. Date: 1998-11-09; US19970064980P Applic. Date: 1997-11-10

Inventor: MAK VIVIEN H W [US]; GRAYSON STEPHEN [US]


Patent No.: US7157439B2  Issued: 02/Jan/2007

Title: HoxD3, HoxA3, and HoxB3 compositions and methods for improved wound healing

Applicant/Assignee: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA

Application No.: 10/746592   Filing Date: 23/Dec/2003

Abstract:

The present invention provides methods and compositions useful in localized transfer of genetic material or proteins. Moreover, the present invention provides methods and compositions for improving and/or controlling wound healing by applying a wound care device comprising HoxD3 and/or HoxA3 and/or HoxB3. In addition, the present invention provides methods and compositions for improved wound healing in subjects having impaired healing capabilities, such as diabetic subjects.

Priority: US2002-305667 Applic. Date: 2002-11-26; WO2002US19020 Applic. Date: 2002-06-14; US20010298688P Applic. Date: 2001-06-14; US20010307632P Applic. Date: 2001-07-24

Inventor: BOUDREAU NANCY [US]; YOUNG DAVID M [US]; MYERS CORNELIA [US]


Patent No.: US7158546B2  Issued: 02/Jan/2007

Title: Composite laser rod, fabricating method thereof, and laser device therewith

Applicant/Assignee: NEC CORPORATION, KONOSHIMA CHEMICAL COMPANY, LTD KONOSHIMA CHEMICAL CO., LTD

Application No.: 10/372836   Filing Date: 26/Feb/2003

Abstract:

As a composite laser rod capable of satisfying the positional stability and output stability of a laser beam, a laser rod in which a laser active element is doped is intimately inserted into a hollow portion of a non-doped ceramic pipe that has a crystal structure the same as the laser rod followed by baking so as to remove a gap and strain at an interface between the laser rod and the ceramic pipe after the baking further followed by polishing a surface of the ceramic pipe to form a ceramic skin layer, and thereby a composite laser rod is formed. In the composite laser rod, an influence due to fluctuation in the cooling capacity of cooling water or a heat sink is averaged by a non-doped skin layer, temperature fluctuation of the laser rod is suppressed, and an influence of vibration from the cooling water or a cooling fan can be suppressed.

When the refractive index of the laser rod is made higher than that of the ceramic pipe, a high efficiency oscillation can be realized, and furthermore when the thermal conductivity of the ceramic pipe is made higher than that of the laser rod, the thermal lens effect can be alleviated.

Priority: JP20020051360 Applic. Date: 2002-02-27

Inventor: KOUTA HIKARU [JP]; SUZUKI YOSHIKAZU [JP]; KUDO SHUETSU [JP]; TSUNEKANE MASAKI [JP]; MUKAIHARA KATSUJI [JP]; YANAGITANI TAKAGIMI [JP]; YAGI HIDEKI [JP]


Patent No.: US7166274B2  Issued: 23/Jan/2007

Title: Synergistically high SPF photoprotective UV-screening compositions comprising insoluble organic sunscreen particles/diarylbutadiene compounds

Applicant/Assignee: SOCIETE L'OREAL S.A L'OREAL

Application No.: 10/463328   Filing Date: 18/Jun/2003

Abstract:

Topically applicable high SPF cosmetic/dermatological UV-screening compositions suited for the photoprotection of the skin and/or hair, comprise (a) particulates of at least one insoluble organic UV-screening agent having a particle size ranging from 10 nm to 5 mum, as a first screening agent, and (b) at least one 4,4-diarylbutadiene compound, as a second screening agent, formulated into a topically applicable, cosmetically/dermatologically acceptable vehicle therefor.

Priority: FR20000016520 Applic. Date: 2000-12-18; WO2001FR03637 Applic. Date: 2001-11-20

Inventor: CANDAU DIDIER [FR]


Patent No.: US7166276B2  Issued: 23/Jan/2007

Title: Silicone elastomer emulsion cosmetic composition comprising colorant inclusive internal phase

Applicant/Assignee: THE PROCTER & GAMBLE COMPANY

Application No.: 10/280525   Filing Date: 25/Oct/2002

Abstract:

The present invention relates to silicone elastomer emulsion cosmetic compositions that comprise an internal phase the further includes a colorant. These compositions are intended to deliver such colorant ingredients to the skin of the user in such a manner as to provide a smooth and even colored appearance. In particular, the present invention relates to a cosmetic composition comprising an emulsion that further comprises: a) a continuous aqueous phase comprising: 1) from about 0.1% to about 10%, by weight of the composition, of a non-emulsifying crosslinked siloxane elastomer

b) a dispersed oil phase comprising: 1) from about 1% to about 25%, by weight of the composition, of an oil compatible colorant

and 2) from about 0.01% to about 20%, by weight of the composition, of a binder

and c) from about 0.01% to about 15%, by weight of the composition, of an emulsifier.

Priority: GB20010025778 Applic. Date: 2001-10-26

Inventor: STEPHENS ALISON FIONA [GB]; JONES NEIL JOHN [GB]; SUNKEL JORGE MAX [US]; VATTER MICHAEL LEE [US]


Patent No.: US7166281B2  Issued: 23/Jan/2007

Title: Pharmaceutical composition and method for relieving itch, pain and swelling resulting from insect bites and stings

Applicant/Assignee: AMERICAN NATURAL TECHNOLOGY SCIENCES, INC

Application No.: 09/845923   Filing Date: 30/Apr/2001

Abstract:

A pharmaceutical composition for relieving the itch, pain, and swelling resulting from insect bites and stings, and methods for producing and using the composition. The method preferably comprises topically applying to the affected area the composition which contains an abrasive ingredient and an anti-itch enzyme, both of which are dispersed in a carrier containing effective amounts of emulsifiers, and/or dispersants and may take the form of a powder, liquid, or paste. The final pharmaceutical composition is preferably made in the form of a cream or lotion so that it can be rubbed directly on the skin at the affected site. The pharmaceutical composition for relieving the itch, pain, and swelling resulting from insect bites and stings disclosed herein may also contain an anesthetic and/or antibiotic.

Priority:

Inventor: KENNEDY PATRICK [US]


Patent No.: US7169401B2  Issued: 30/Jan/2007

Title: Topical skin care composition containing refined peanut oil

Applicant/Assignee: HILL DERMACEUTICALS, INC

Application No.: 10/892153   Filing Date: 16/Jul/2004

Abstract:

A vehicle containing refined peanut oil for topical use in skin care and for use in skin care therapeutics, and a process for making the vehicle and a composition and therapeutic composition made from that process.

Priority: US2003-622560 Applic. Date: 2003-07-18; US20030507117P Applic. Date: 2003-10-01

Inventor: PUGLIA NANCY [US]; ROTH JERRY [US]; RAMIREZ ROSARIO [US]


Patent No.: US7169811B2  Issued: 30/Jan/2007

Title: Composition based on ethyl ester of linoleic acid and triethyl ester of citric acid for topical use in the treatment of seborrhea and acne

Applicant/Assignee: GENERAL TOPICS S.R.L

Application No.: 10/322566   Filing Date: 16/Dec/2002

Abstract:

The present invention relates to a composition for topical use for treating and improving the aesthetic conditions of the skin, which comprises, as an active ingredient, a mixture of ethyllinoleate and triethylcitrate. This composition is active in the treatment of seborrhea and acne.

Priority: IT2001BS00111 Applic. Date: 2001-12-20

Inventor: DE PAOLI AMBROSI GIANFRANCO [IT]


Patent No.: US7171264B1  Issued: 30/Jan/2007

Title: Intradermal delivery of active agents by needle-free injection and electroporation

Applicant/Assignee: GENETRONICS, INC

Application No.: 10/339708   Filing Date: 08/Jan/2003

Abstract:

Methods are proved for introducing a biologically active agent into cells of a subject by introducing the agent in a form suitable for electrotransport into a region of tissue of the subject using one or more needle-free injectors, and applying a pulsed electric field to the region of tissue, thereby causing electroporation of the region of tissue. The combination of needle-free injection and electroporation is sufficient to introduce the agent into cells in skin, muscle or mucosa. For example, the region of tissue can be contacted with two oppositely charged injectors, one acting as the donor electrode and one acting as the counter electrode, or a single injector and one or more electrodes can be used. In addition, needle-free injection may be used in combination with suitable non-invasive electrode configurations. The active agents delivered into cells using the invention method can be small molecules, polynucleotides, polypeptides, and the like.

Priority: US2000-567404 Applic. Date: 2000-05-08; US19990133265P Applic. Date: 1999-05-10

Inventor: HOFMANN GUNTER A [US]; RABUSSAY DIETMAR P [US]; ZHANG LEI [US]


Patent No.: US7172753B2  Issued: 06/Feb/2007

Title: Photoprotective UV-screening compositions comprising triazine/dibenzoylmethane/diarylbutadiene compounds

Applicant/Assignee: SOCIETE L'OREAL S.A L'OREAL

Application No.: 10/463432   Filing Date: 18/Jun/2003

Abstract:

Topically applicable, photostable cosmetic/dermatological UV-screening compositions suited for photoprotecting the skin and the hair, comprise (a) at least one UV-screening dibenzoylmethane compound, (b) at least one UV-screening 1,3,5-triazine compound that is photosensitive in the presence of a dibenzoylmethane compound, and (c) a 1,3,5-triazine photostabilizing amount of at least one 4,4-diarylbutadiene compound, formulated into a topically applicable, cosmetically/dermatologically acceptable support therefor

the weight ratio of the 4,4-diarylbutadiene compound(s) to the dibenzoylmethane compound(s) is characteristically greater than 2.5 and the subject compositions are advantageously devoid of any cinnamate sunscreen.

Priority: FR20000016517 Applic. Date: 2000-12-18; WO2001FR03639 Applic. Date: 2001-11-20

Inventor: CANDAU DIDIER [FR]


Patent No.: US7172859B2  Issued: 06/Feb/2007

Title: System and method for optimizing tissue barrier transfer of compounds

Applicant/Assignee: TRANSFORM PHARMACEUTICALS, INC

Application No.: 10/371372   Filing Date: 20/Feb/2003

Abstract:

The present invention relates to high-throughput systems and methods to prepare a large number of component combinations, at varying concentrations and identities, at the same time, and high-throughput methods to test tissue barrier transfer, such as transdermal transfer, of components in each combination. The methods of the present invention allow determination of the effects of inactive components, such as solvents, excipients, enhancers, adhesives and additives, on tissue barrier transfer of active components, such as pharmaceuticals. The invention thus encompasses the high-throughput testing of pharmaceutical compositions or formulations in order to determine the overall optimal composition or formulation for improved tissue transport, such as transdermal transport.

Priority: US2001-904725 Applic. Date: 2001-07-13; US20000220324P Applic. Date: 2000-07-24; US20000218377P Applic. Date: 2000-07-14

Inventor: CIMA MICHAEL J [US]; CHEN HONGMING [US]; GYORY J RICHARD [US]


Patent No.: US7175834B2  Issued: 13/Feb/2007

Title: Sunscreen composition with enhanced SPF and water resistant properties

Applicant/Assignee: ENGELHARD CORPORATION

Application No.: 11/114668   Filing Date: 26/Apr/2005

Abstract:

The present invention relates to a sunscreen formulation which exhibits superior ultraviolet protection and water resistance than prior art sunscreen compositions. The sunscreen formulation comprises (a) a dispersion comprising a sunscreen active agent and (b) a base composition comprising a rheological modifying agent and water. The sunscreen formulation is substantially free of surfactants. According to a preferred embodiment, the sunscreen active agent is ethylhexylmethoxycinnamate, butylmethoxydibenzoylmethane, or a combination thereof. The sunscreen formulation preferably comprises a phosphorylated starch derivative as a rheological modifying agent. Another embodiment of the present invention is a method of protecting skin or hair from ultraviolet radiation by applying an effective amount of the sunscreen formulation of the present invention to the skin or hair.

Priority: US2003-332393 Applic. Date: 2003-04-29; WO2001US21588 Applic. Date: 2001-07-09; US20000216573P Applic. Date: 2000-07-07

Inventor: AUST DUNCAN T [US]; WILMOTT JAMES M [US]; HAYWARD JAMES A [US]


Patent No.: US7175853B1  Issued: 13/Feb/2007

Title: Therapeutic system which can be moisture-activated

Applicant/Assignee: LTS LOHMANN THERAPIE-SYSTEME AG

Application No.: 09/647289   Filing Date: 15/Nov/2000

Abstract:

This invention provides for a therapeutic system for timed and controlled release of at least one therapeutic active agent to a human or animal organism by diffusion through the skin or mucous membrane. The active agent is initially present, for the purposes of manufacture and storage, in a first state in the form of a pharmaceutically acceptable salt, which is chemically stable and insufficiently permeable for the skin or mucous membrane. The active agent is converted at the application site upon access of moisture and by an activating agent into a second state, which is suitable for diffusion through the skin or mucous membrane and in which it is taken up by the organism. The activating agent is initially present as a solid substance or a mixture or a plurality of such substances, which reacts in aqueous solution as an acid or base. The activating agent contains a portion of water of at least 5% in its solid body structure, either intercalated or bound thereto.

Priority: DE19981014087 Applic. Date: 1998-03-30; WO1999EP01802 Applic. Date: 1999-03-18

Inventor: BRACHT STEFAN [DE]


Patent No.: US7179495B1  Issued: 20/Feb/2007

Title: Hyperforin as cytostatic agent and hyperforin ointment or cream as application form

Applicant/Assignee: UNIVERSITAETSKLINIKUM FREIBURG

Application No.: 09/856694   Filing Date: 24/Nov/1999

Abstract:

The invention relates to the use of hyperforin for treating cancer diseases and/or precancerous stages. In addition, the invention relates to a hyperforin-containing ointment or cream and to its production and use. The hyperforin-containing ointment or cream is also suitable for treating inflammatory skin diseases, geriatric skin and bacterial skin diseases and also skin diseases in the sphere of veterinary medicine.

Priority: DE19981054446 Applic. Date: 1998-11-25; DE19991013333 Applic. Date: 1999-03-24; WO1999EP09067 Applic. Date: 1999-11-24

Inventor: SIMON JAN C [DE]; SCHEMPP CHRISTOPH M [DE]; SCHOEPF ERWIN [DE]; SIMON-HAARHAUS BIRGIT [DE]


Patent No.: US7181693B1  Issued: 20/Feb/2007

Title: Affective control of information systems

Applicant/Assignee: GATEWAY INC

Application No.: 09/528254   Filing Date: 17/Mar/2000

Abstract:

An information system that determines the apparent emotional state of the user and, based upon that determination, reacts appropriately. Appropriate reactions of the system include marking user text input to convey the apparent emotional state of the user to recipients. Other embodiments incorporate reactions of the system that warn or prompt a user, prior to system execution of a user directed operation, when the system has determined that the apparent emotional state of the user merits a warning or a prompt.

Priority:

Inventor: ANDERSON GLEN JOHN [US]; MCKNIGHT RUSSELL F [US]


Patent No.: US7182963B2  Issued: 27/Feb/2007

Title: Cosmetic and dermopharmaceutical compositions for skin prone to acne

Applicant/Assignee: SEDERMA

Application No.: 10/817670   Filing Date: 02/Apr/2004

Abstract:

The invention relates to the use of an extract of olive leaves (Olea europaea) which is titrated in oleanolic acid and which may or may not be associated with a Larrea divaricata extract which is titrated in nordihydroguaiaretic acid (NDGA). Said products are intended for all types of cosmetic and dermopharmaceutical compositions for all forms of skin care, for moisturizing and anti-inflammatory purposes and, in particular, for the prevention and treatment of skin prone to acne.

Priority: FR20010012802 Applic. Date: 2001-10-03; WO2002FR03344 Applic. Date: 2002-10-01

Inventor: LINTNER KARL [FR]


Patent No.: US7182966B2  Issued: 27/Feb/2007

Title: Microbiological control in poultry processing

Applicant/Assignee: ALBEMARLE CORPORATION

Application No.: 11/103703   Filing Date: 11/Apr/2005

Abstract:

In the processing of poultry, equipment, instruments, apparatus and/or water used in such processing, and/or carcasses and/or parts of poultry resulting from the processing of poultry, are disinfected with aqueous solutions of certain halogen-based microbiocides, especially certain bromine-based microbiocides. Described are the particular microbiocides used and the substantial advantages of using such materials, in some cases as concentrated solutions and in other cases as dilute solutions.

Priority: US2001-029329 Applic. Date: 2001-12-21; US2001-893581 Applic. Date: 2001-06-28

Inventor: HOWARTH JONATHAN N [US]


Patent No.: US7183315B2  Issued: 27/Feb/2007

Title: Silver salts of sucrose-octasulphate

Applicant/Assignee: INTERALIA S.R.L

Application No.: 10/492342   Filing Date: 09/Apr/2004

Abstract:

The described invention relates to the new compound "sucrose-octasulphate salified with silver" usefully applicable in the prevention and cure of infections by micro-organisms of bacterial, fungal, viral and/or yeast origins and in the promotion of tissue repair. The silver salts of sucrose octasulphate, subject of the invention have in fact been shown to possess antimicrobial activities even higher than that of known silver compounds. These properties therefore make them particularly suitable for use in different pathological or paraphysiological conditions of the skin, of the epithelia and of the mucosa both intact and lesioned.

Priority: WO2002EP11627 Applic. Date: 2002-10-17; IT2001MI02188 Applic. Date: 2001-10-19

Inventor: CALDERINI GABRIELLA [IT]; PROSDOCIMI MARCO [IT]; ANTICO CLAUDIO [IT]; MIGLIERINI GIULIANA [IT]; CASADEI MASSARI DANILO [IT]


Patent No.: US7183351B2  Issued: 27/Feb/2007

Title: Hydrophilic adhesive compositions

Applicant/Assignee: LABORATOIRES URGO

Application No.: 10/514259   Filing Date: 15/Oct/2004

Abstract:

The present invention relates to novel hydrophilic adhesive compositions, characterised in that they comprise a thermoplastic elastomer of poly(styrene-olefin-styrene) block copolymer type, a tackifying product, a liquid plasticizer, water and un amphiphilic copolymer. The invention also relates to the use of these novel hydrophilic adhesive compositions as adhesives for fixing any type of product, and notably products for medical, dermatological or cosmetological purposes, which come into contact with a wound, the skin or the mucous membranes.

Priority: FR20020004779 Applic. Date: 2002-04-17; WO2003FR01210 Applic. Date: 2003-04-16

Inventor: AUGUSTE STEPHANE [FR]; DESMAISON NADEGE [FR]


Patent No.: US7186416B2  Issued: 06/Mar/2007

Title: Foamable pharmaceutical compositions and methods for treating a disorder

Applicant/Assignee: STIEFEL LABORATORIES, INC

Application No.: 10/445487   Filing Date: 28/May/2003

Abstract:

Novel compositions of matter comprising a foamable delivery system are provided. Novel methods for treating a disease, disorder, or condition using the novel compositions are further provided. Novel methods for making and delivering a foamable pharmaceutical composition are also provided. While the novel compositions and foamable drug delivery system may be utilized for administration of a wide variety of drugs to epithelial tissues, to treat a wide variety of diseases, disorders, or conditions, the inventive compositions and foamable drug delivery systems are particularly useful for the dermatological administration of corticosteroids and antifungal agents.

Priority:

Inventor: POPP KARL F [US]; YUHAS EDWARD R [US]


Patent No.: US7186674B2  Issued: 06/Mar/2007

Title: Topical cleansing composition

Applicant/Assignee: L'OREAL

Application No.: 09/901907   Filing Date: 11/Jul/2001

Abstract:

A cleansing composition, which comprises at least one phosphate surfactant, at least one foaming nonionic surfactant and at least one cationic polymer devoid of saccharide groups in an aqueous medium, the composition having the appearance of a transparent gel.

Priority: FR20000009111 Applic. Date: 2000-07-12

Inventor: GUILLOU VERONIQUE [FR]; SEBILLOTTE-ARNAUD LAURENCE [FR]; BORDEAUX DOMINIQUE [FR]


Patent No.: US7186685B2  Issued: 06/Mar/2007

Title: Compositions comprising gelatin-glycine and carotenoids

Applicant/Assignee: MAVI SUD S.R.L

Application No.: 11/177500   Filing Date: 11/Jul/2005

Abstract:

The invention relates to cosmetic and pharmaceutical agents and compositions useful in the treatment of those phenomena and manifestations generally causing or accompanying the aging of skin, ocular tissues and other tissues. In particular the invention relates to the use of different mixture of carotenoids, preferably lutein, and gelatin-glycine for improving hydration, elasticity and lipid content of the skin and for protecting skin and ocular tissues from hazardous radiations.

Priority: EP20040103266 Applic. Date: 2004-07-09

Inventor: MORGANTI PIERFRANCESCO [IT]; ROBERTS RICHARD LEE [US]


Patent No.: US7186756B2  Issued: 06/Mar/2007

Title: Steroid derivatives and use thereof as medicaments

Applicant/Assignee: INOVAT

Application No.: 10/567590   Filing Date: 23/Jul/2004

Abstract:

Steroids of the formula wherein R is defined as in the application capable of increasing the synthesis of collagen.

Priority: FR20030009099 Applic. Date: 2003-07-25; WO2004FR01990 Applic. Date: 2004-07-23

Inventor: GUTIERREZ GILLES [FR]; SERRAR MOSTAFA [FR]; HADID ZOHRA [FR]


Patent No.: US7188666B2  Issued: 13/Mar/2007

Title: Heat exchanger of ventilating system

Applicant/Assignee: LG ELECTRONICS INC

Application No.: 10/538070   Filing Date: 04/Feb/2003

Abstract:

A heat exchanger of a ventilating system includes: heat exchange plates having first air passage through which indoor air being discharged to outside of a building passes and a second air passage through which outdoor air being introduced to the interior of the building passes which are sequentially formed: first corrugation plates attached to the first air passage

and second corrugation plates attached to the second air passage, wherein the heat exchange plates are made of a paper material with numerous fine holes that are able to generate a capillary phenomenon and loess which radiates far infrared ray. Heat exchange and moisture exchange between the indoor air and the outdoor air are performed simultaneously, and a cleaning function of removing a harmful material contained in outdoor air can be carried out.

Priority: WO2003KR00245 Applic. Date: 2003-02-04

Inventor: LEE SEONG-HWAN [KR]; CHO MIN-CHUL [KR]; SHIN SOO-YEON [KR]


Patent No.: US7192597B2  Issued: 20/Mar/2007

Title: Composition for treatment of skin, hair and nails

Applicant/Assignee: KUHS GMBH

Application No.: 11/135459   Filing Date: 24/May/2005

Abstract:

A composition, especially for treatment of aged and/or stressed skin, the composition containing, in addition to water, at least one substance that forms lamellar structures with water. The composition further contains S-adenosylmethionine and/or at least one compound that contains a functional group of the general formula -CH2-N<+>-(CH3)3. The lamellar structure has a layer structure in which an upper layer of the substance is aligned with a lower layer, the hydrophilic groups of the substance each point outwards, and the lipophilic groups of the substance are aligned inwards with one another. The lamellar structure is surrounded by a hydrophilic medium, preferably water.

Priority: DE20001008850 Applic. Date: 2000-02-25; US2002-203993 Applic. Date: 2002-12-09; WO2001DE00615 Applic. Date: 2001-02-19

Inventor: ALBRECHT MARTIN [DE]; GHYCZY MIKLOS [DE]


Patent No.: US7192599B2  Issued: 20/Mar/2007

Title: Mattifying oil-in-water emulsion

Applicant/Assignee: MMP, INC

Application No.: 10/162472   Filing Date: 03/Jun/2002

Abstract:

The present invention relates to cosmetic and pharmaceutical oil-in-water emulsions which have a mattifying effect when applied to the skin. The invention comprises a hydrophilic, non-organically modified magnesium aluminum silicate or a bentonite clay and a polyol in the water phase

and a volatile, skin-compatible, lipophilic solvent and a high melting point lipophilic plasticizer in the oil phase. A preferred surfactant system to stabilize the emulsion includes non-toxic metal alkyl sulfates and/or sucrose esters.

Priority:

Inventor: MERCIER MICHEL F [US]; THAU PAUL [US]; CHASE JOHN A [US]


Patent No.: US7192617B2  Issued: 20/Mar/2007

Title: Whitening agent, skin preparation for external use and cosmetic

Applicant/Assignee: NICHIREI BIOSCIENCE INC NICHIREI BIOSCIENCES INC

Application No.: 10/537958   Filing Date: 22/Jul/2005

Abstract:

The invention relates to a whitening agent that makes effective use of camu camu seeds, which have conventionally been discarded, and that has high safety and whitening effect useful in cosmetics and the like, as well as skin preparations for external use and cosmetics containing the whitening agent. The whitening agent of the present invention contains camu camu seed extract as an active component, and the skin preparations for external use and cosmetics of the present invention contain the whitening agent.

Priority: JP20020362507 Applic. Date: 2002-12-13; WO2003JP15656 Applic. Date: 2003-12-08

Inventor: NAGAMINE KENICHI [JP]; HAYASHI MIKI [JP]; YAMASAKI KAORI [JP]


Patent No.: US7192896B2  Issued: 20/Mar/2007

Title: Disposable cleaning product

Applicant/Assignee: 3M INNOVATIVE PROPERTIES COMPANY

Application No.: 10/001158   Filing Date: 15/Nov/2001

Abstract:

The invention is directed at a disposable dry cleansing article that is formed from a melt extruded fibrous web that has incorporated into the fibers forming the web from 0.5 to 20 percent by weight of a melt extruded lathering surfactant. The invention, dry article generally comprises a melt extruded fibrous web of a thermoplastic polymer having a basis weight of from about 10 to 200 g/m<2>, preferably 10 to 150 g/m<2 >wherein the fibers have a lathering surfactant incorporated into the fiber at a level that allows the article to be used two (2) or more times with a rinse foam volume of 15 or more, with an initial foam volume of at least 50 ml. The novel melt extruded web can be made by the following sequential steps: (a) providing to an extruder a thermoplastic resin, such as polypropylene

(b) blending into the resin a lathering surfactant at a temperature at which the surfactant is not significantly degraded

(c) forming the blend into melt extruded fibers, (d) collecting the fibers, (e) forming the fibers into a web and optionally, further treating the web by coating additional components, laminating to further layers or consolidating for strength or the like.

Priority:

Inventor: SETH JAYSHREE [US]; HALL JERRY W [US]


Patent No.: US7196117B2  Issued: 27/Mar/2007

Title: Use of cationic surfactant as activity enhancer in deodorants and oral care

Applicant/Assignee: LABORATORIOS MIRET, S.A

Application No.: 10/494926   Filing Date: 07/May/2004

Abstract:

Antimicrobial system which comprises a cationic surfactant, derived from the condensation of fatty acids and esterified dibasic amino acids, according to the following formula (I), where: X is Br, Cl or HSO4R1: is linear alkyl chain from an saturated fatty acid, or hydroxyacid from 8 to 14 atoms of carbon bonded to the alpha-amino acid group through amidic bond. R2 is a linear or branched alkyl chain from 1 to 18 carbon atoms or aromatic. R3: is Formula (II), where n can be from 0 to 4, and at least one antimicrobial agent characterised for its enhanced activity.

Priority: WO2001EP13221 Applic. Date: 2001-11-15

Inventor: BELTRAN JOAN BAPTISTA URGELL [ES]; BONAVENTURA JOAN SEGUER [ES]


Patent No.: US7198800B1  Issued: 03/Apr/2007

Title: Compositions and methods

Applicant/Assignee:

Application No.: 09/717088   Filing Date: 22/Nov/2000

Abstract:

Non-aerosol spray-on skin patch compositions as described comprising at least one substantially water insoluble film forming agent, at least one film plasticizer agent, at least one water soluble compound, and at least one organic solvent, the composition forming a flexible, porous and physiologically compatible skin patch when sprayed on to skin and allowed to dry. Also described are methods of improving wound healing by administering a physiologically active ingredient to a patient in need of such treatment.

Priority: AU1999PQ04190 Applic. Date: 1999-11-23

Inventor: KO THOMAS SAI YING [AU]


Patent No.: US7199090B2  Issued: 03/Apr/2007

Title: High alcohol content gel-like and foaming compositions comprising an alcohol and fluorosurfactant

Applicant/Assignee: ETHENA HEALTHCARE INC

Application No.: 10/952474   Filing Date: 29/Sep/2004

Abstract:

This invention relates to a "high lower alcohol content" (>40% v/v of a C1-4 alcohol) liquid composition able to be either dispensed as a stable foam with the use of non-propellant foam dispensing devices from non-pressurized containers or as an alcohol gel composition which does not use thickener and gelling agents that leave undesirable deposits or a sticky after-feel and that has a final viscosity less than 4,000 cps. The liquid compositions comprise an alcohol, C1-4 (>40% v/v), a fluorosurfactant of at least 0.001% by weight to prepare a foamable composition or from 0-2.0% to prepare a gel-like composition of a final viscosity less than 4,000 cps, 0-10% w/w of additional minor components added to obtain the desired performance (a foamable composition or a gel-like composition with a viscosity less than 4,000 cps), and the balance being purified water.

The compositions may include emulsifier-emollients and mosturizers, secondary surfactants, foam stabilizers, fragrances, antimicrobial agents, other type of medicinal ingredients, and the like ingredients or additives or combinations thereof commonly added to alcohol gels or foams, aerosol compositions or to toiletries, cosmetics, pharmaceuticals and the like.

Priority: US20030506172P Applic. Date: 2003-09-29; US20040591601P Applic. Date: 2004-07-28

Inventor: KOIVISTO BRUCE MICHAEL [US]; DE CASTRO MARIA TERESA FERNAND [US]


Patent No.: US7199101B2  Issued: 03/Apr/2007

Title: Gelling agent for oil

Applicant/Assignee: AJINOMOTO CO., INC

Application No.: 10/987726   Filing Date: 12/Nov/2004

Abstract:

A gelling agent for an oil, which contains at least one compound (A) and at least one compound (B), and a gel composition containing the gelling agent and an oil:

Priority: JP20030382921 Applic. Date: 2003-11-12

Inventor: HATAJIMA TOSHIHIKO [JP]; YAMATO NAOYA [JP]; HATTORI TATSUYA [JP]


Patent No.: US7201765B2  Issued: 10/Apr/2007

Title: Method and apparatus for acne treatment

Applicant/Assignee: LIGHT BIOSCIENCE, LLC LIGHT BIOSCIENCE LLC

Application No.: 11/119378   Filing Date: 02/May/2005

Abstract:

Disclosed is a system and method for treatment of skin disorders. More particularly, the disclosed invention is directed toward the treatment of acne and acne scarring by treating sebaceous oil glands and the surrounding tissue with an exogenous chromophore composition and then exposing the target tissue to visible, infrared, or ultraviolet light to inhibit the activity of the oil gland and eliminate acne bacteria. The treatment method of the present invention may be futher augmented by enhancing the penetration of the topical composition into the oil gland and surrounding tissue through the use of procedures including enzyme peeling, microderm abrasion, or ultrasound.

Priority: US2001-933870 Applic. Date: 2001-08-22; US2001-819082 Applic. Date: 2001-02-15; US1998-203178 Applic. Date: 1998-11-30

Inventor: MCDANIEL DAVID H [US]


Patent No.: US7201893B2  Issued: 10/Apr/2007

Title: Stabilization of UV-sensitive active ingredients

Applicant/Assignee: BEIERSDORF AG

Application No.: 10/789750   Filing Date: 27/Feb/2004

Abstract:

Cosmetic and dermatological formulations containing at least one UV-sensitive active ingredient have increased UV protection and have the active ingredient stabilized against decomposition through addition of at least one dialkyl naphthalate of the structural formula

Priority: DE20011041474 Applic. Date: 2001-08-29; WO2002EP09309 Applic. Date: 2002-08-21

Inventor: WENDEL VOLKER [DE]; GOEPPEL ANJA [DE]


Patent No.: US7204974B2  Issued: 17/Apr/2007

Title: Stabilization of oxidation-sensitive or UV-sensitive active ingredients

Applicant/Assignee: BEIERSDORF AG

Application No.: 10/789641   Filing Date: 27/Feb/2004

Abstract:

The invention is a cosmetic or dermatological formulation, compris

Priority: DE20011041475 Applic. Date: 2001-08-29; WO2002EP09310 Applic. Date: 2002-08-21

Inventor: HEINSOHN GUIDO [DE]; GOEPPEL ANJA [DE]; WENDEL VOLKER [DE]


Patent No.: US7208143B2  Issued: 24/Apr/2007

Title: Antiperspirant compositions

Applicant/Assignee: ISP INVESTMENTS INC

Application No.: 10/952949   Filing Date: 29/Sep/2004

Abstract:

What is described herein is an antiperspirant composition including an active antiperspirant ingredient, and a phenylethyl, benzyl or substituted benzyl ester as additive therein, which is an aryl carboxylic ester of 2-phenylethyl alcohol, 1-phenylethyl alcohol or benzyl alcohol, which leaves a reduced visible white chalky residue on the skin of the user.

Priority:

Inventor: BERTZ STEVEN H [US]; OROFINO STEVEN A [US]; GOMEZ BLANCA [US]


Patent No.: US7208168B2  Issued: 24/Apr/2007

Title: Segmented composition and a method and a system for making same

Applicant/Assignee: AVON PRODUCTS, INC

Application No.: 11/124502   Filing Date: 06/May/2005

Abstract:

There is provided a method of forming a segmented composition utilizing the thermal exchange properties of a first component that solidifies when cooled, and a second component that solidifies when heated. When an amount of the heat from the first component is transferred to the coolness of the second component, and vice versa, both the first and second components are provided with structural integrity, thus forming the segmented composition. There is also provided a method and an apparatus that can form a segmented cosmetic composition. The segmented cosmetic composition has at least two components. A first component is preferably a molten wax. A second component is preferably a smectite clay dispersion. One of the components fully surrounds, partially surrounds, or is adjacent to the other component.

Priority: US2000-750936 Applic. Date: 2000-12-29

Inventor: FLEISSMAN LEONA G [US]; SANTINI ANTHONY M [US]


Patent No.: US7208460B2  Issued: 24/Apr/2007

Title: Multi component controlled delivery system for soap bars

Applicant/Assignee: SALVONA IP, LLC

Application No.: 10/948971   Filing Date: 24/Sep/2004

Abstract:

The present invention relates to an improved controlled delivery system that can be incorporated in soap bars to enhance deposition of active ingredients and sensory markers onto skin. The carrier system also provides controlled release or prolonged release of these actives from the skin over an extended period of time. The controlled delivery system of the present invention comprises substantially free-flowing, powder formed of solid hydrophobic, positively charged, nanospheres of encapsulated active ingredients, that are encapsulated in moisture sensitive microspheres. The high cationic charge density of the nanosphere improves deposition of active ingredients onto skin.

The high cationic charge density on the nanosphere surface is created by incorporating a cationic conditioning agent into the solid hydrophobic matrix of the nanospheres, by incorporating a cationic charge "booster" in the moisture sensitive microsphere matrix, or by using a cationic conditioning agent in the nanosphere matrix in conjunction with a cationic charge "booster" in the microsphere matrix. The invention also pertains to soap products comprising the controlled release system of the present invention.

Priority: US2002-286143 Applic. Date: 2002-11-01; US2002-133833 Applic. Date: 2002-04-26

Inventor: SHEFER ADI [US]; SHEFER SAMUEL [US]


Patent No.: US7211268B2  Issued: 01/May/2007

Title: Preparation of polysaccharide betainate type compounds, compounds obtained, their use and compositions comprising them

Applicant/Assignee: L'OREAL S.A

Application No.: 10/294685   Filing Date: 15/Nov/2002

Abstract:

A process for preparing compounds from the polysaccharide betainate family, novel compounds so obtained, and their use in cosmetics or in dermatology, as well as the compositions, such as cosmetic or dermatological compositions, comprising said novel compounds.

Priority: FR20010014789 Applic. Date: 2001-11-15

Inventor: DUBIEF CLAUDE [FR]; RINAUDO MARGUERITE [FR]; AUZELY-VELTY RACHEL [FR]


Patent No.: US7214365B2  Issued: 08/May/2007

Title: Stablization of oxidation-sensitive or UV-sensitive active ingredients

Applicant/Assignee: BEIERSDORF AG

Application No.: 10/789881   Filing Date: 27/Feb/2004

Abstract:

Cosmetic and dermatological formulations comprising at least one hydrophilic active ingredient and at least one dialkyl naphthalate which is characterized by the structural formula in which R<1 >and R<2>, independently of one another, are selected from the group of branched and unbranched alkyl groups having 6 to 24 carbon atoms, have been found to be stable and effective, particularly in moisturizing the skin or protection the skin from skin aging.

Priority: DE20011041472 Applic. Date: 2001-08-29; WO2002EP09374 Applic. Date: 2002-08-22

Inventor: WENDEL VOLKER [DE]; GOEPPEL ANJA [DE]


Patent No.: US7214395B2  Issued: 08/May/2007

Title: Pharmaceutical and cosmetic composition against skin aging

Applicant/Assignee: INDENA S.P.A

Application No.: 10/477703   Filing Date: 14/Nov/2003

Abstract:

Pharmaceutical and cosmetic compositions for the prevention of skin aging, containing phospholipid complexes of extracts of Vitis vinifera, and phospholipid complexes of standardized extract from Centella asiatica.

Priority: WO2002EP05147 Applic. Date: 2002-05-10; IT2001MI01022 Applic. Date: 2001-05-17

Inventor: DI PIERRO FRANCESCO [IT]


Patent No.: US7217423B2  Issued: 15/May/2007

Title: Revitalising active complex for the skin

Applicant/Assignee: COTY B.V

Application No.: 10/250392   Filing Date: 30/Jun/2003

Abstract:

The invention relates to a revitalizing active complex for the skin and cosmetic products produced thereby. Said active complex for the skin consists of between 0.5 and 9 wt. % of creatine or a creatine derivative, between 0.1 and 40 wt. % of water-soluble glycogen, between 0.1 and 10 wt. % of a phospholipid, and between 0.1 and 5 wt. % of a cosmetically acceptable gel, water making up the remainder of the 100 wt. %, said mixture of creatine, glycogen and phospholipid being homogeneously distributed in the aqueous gel.

Priority: DE20011006288 Applic. Date: 2001-02-02; WO2002DE00363 Applic. Date: 2002-01-29

Inventor: GOLZ-BERNER KARIN [DE]; ZASTROW LEONHARD [DE]


Patent No.: US7217424B2  Issued: 15/May/2007

Title: Compositions containing esters of aromatic alkoxylated alcohols and fatty carboxylic acids

Applicant/Assignee: CRODA, INC

Application No.: 10/272556   Filing Date: 16/Oct/2002

Abstract:

A personal care or cosmetic product composition that includes from about 0.1% to about 99% of at least one ester of alkoxylated aromatic alcohol and fatty carboxylic acid, and from about 0.1% to 60% of at least one functional ingredient is provided. The functional ingredients in the composition may include active ingredients and additional ingredients. Especially suitable active ingredients are sunscreen active ingredients and antiperspirant active ingredients. Preferred compositions are sunscreen product formulations and antiperspirant products. In one preferred embodiment, the composition further includes at least one cyclomethicone compound present in the amount of from about 1% to 99% by weight of the composition.

A method of improving the protection of human or animal skin or hair from radiation and a method of improving the protection of human or animal skin or hair from perspiration are also provided.

Priority: US20010330208P Applic. Date: 2001-10-17

Inventor: PEREIRA ABEL [US]; WESTERGOM CHRISTOPHER [US]; OBUKOWHO PATRICK [US]


Patent No.: US7217821B2  Issued: 15/May/2007

Title: Photoprotective cosmetic compositions comprising para-aminobenzalmalonate-substituted s-triazine compounds

Applicant/Assignee: L'OREAL

Application No.: 10/829440   Filing Date: 22/Apr/2004

Abstract:

Cosmetic/dermatological sunscreen compositions, suited for photoprotecting, e.g., the skin, lips, scalp and/or hair against the damaging effects of UV-radiation, contain thus effective amounts of at least one novel s-triazine compound tri-substituted with para-aminobenzalmalonate substituents.

Priority: FR20030004922 Applic. Date: 2003-04-22; US20030483651P Applic. Date: 2003-07-01

Inventor: RICHARD HERVE [FR]


Patent No.: US7217853B2  Issued: 15/May/2007

Title: Composition for cushions, wound dressings and other skin-contacting products

Applicant/Assignee: CORIUM INTERNATIONAL, INC

Application No.: 10/227623   Filing Date: 21/Aug/2002

Abstract:

A skin-contacting adhesive composition is described which has improved initial tack, long-term adhesion, water uptake and translucency characteristics and may be prepared by melt extrusion. Uses of these compositions are also described, for example, their use in wound dressings.

Priority: US20020383504P Applic. Date: 2002-05-24

Inventor: KULICHIKHIN VALERY G [RU]; PARANDOOSH SHOREH [US]; FELDSTEIN MIKHAIL M [RU]; ANTONOV SERGEY [RU]; CLEARY GARY W [US]


Patent No.: US7223382B2  Issued: 29/May/2007

Title: Cosmetic compositions containing rosemary extract and dha

Applicant/Assignee: E-L MANAGEMENT CORPORATION

Application No.: 10/451565   Filing Date: 20/Jun/2003

Abstract:

The present invention relates to a topical composition comprising a malodor-reducing effective amount of a rosemary extract, or active fraction thereof, in combination with a self-tanning effective amount of DHA. The invention also provides a method of reducing the potential for malodor generation of a DHA composition comprising adding to the composition an effective amount of rosemary extract or active fraction thereof.

Priority: WO2002US16766 Applic. Date: 2002-05-29

Inventor: SOKOLINSKY MARINA [US]; OSTROVSKAYA ASIRA [US]; LANDA PETER A [US]; MAES DANIEL H [US]


Patent No.: US7223386B2  Issued: 29/May/2007

Title: Preparations for topical skin use and treatment

Applicant/Assignee: GENENCOR INTERNATIONAL, INC

Application No.: 10/660101   Filing Date: 10/Sep/2003

Abstract:

Topical preparations for release of an active agent and to methods of making and using the topical preparations are provided. The preparations may have an internal phase dispersed within an external phase. The internal phase may be a hydrophilic carrier and an active agent. The external phase may be a silicone matrix.

Priority: US2003-385213 Applic. Date: 2003-03-10; US20020363386P Applic. Date: 2002-03-11; US20030439862P Applic. Date: 2003-01-14

Inventor: BOTT RICHARD R [US]; GEBERT MARK S [US]; KLYKKEN PAAL CHRISTIAN [US]; MAZEAUD ISABELLE [FR]; THOMAS XAVIER JEAN-PAUL [US]


Patent No.: US7226581B2  Issued: 05/Jun/2007

Title: Bodywashes containing additives

Applicant/Assignee: AQUEA SCIENTIFIC CORPORATION

Application No.: 11/350397   Filing Date: 07/Feb/2006

Abstract:

The invention encompasses bodywashes containing an additive. The additive may contain a sunscreen. The additive may contain 2, 3, or more than three sunscreens. Optionally, one or more of the sunscreens may be encapsulated. The invention further encompasses methods of making and using bodywashes containing an additive, e.g., an additive containing a sunscreen.

Priority: US2005-076517 Applic. Date: 2005-03-08; US2005-076565 Applic. Date: 2005-03-08; US2005-076089 Applic. Date: 2005-03-08; US2005-076088 Applic. Date: 2005-03-08; US2005-076507 Applic. Date: 2005-03-08; US20050648961P Applic. Date: 2005-01-31

Inventor: TRAYNOR DANIEL HENRY [US]; MARKOWITZ STEVEN M [US]; COMPTON DAVID L [US]; TRAYNOR HENRY G [US]; DULAK MICHAEL [US]


Patent No.: US7226582B2  Issued: 05/Jun/2007

Title: Sunscreen compositions and methods of use

Applicant/Assignee: AQUEA SCIENTIFIC CORPORATION

Application No.: 11/350409   Filing Date: 07/Feb/2006

Abstract:

The invention encompasses additives for addition to a bodywash, where the additives contain one or more sunscreens, and where a bodywash which contains the additive imparts to the skin an SPF of at least about 2, in some cases at least about 5, or 10, or 15. Also described are methods of making and using the additives.

Priority: US2005-076565 Applic. Date: 2005-03-08; US2005-076088 Applic. Date: 2005-03-08; US2005-076089 Applic. Date: 2005-03-08; US2005-076517 Applic. Date: 2005-03-08; US2005-076507 Applic. Date: 2005-03-08; US20050648961P Applic. Date: 2005-01-31

Inventor: TRAYNOR DANIEL HENRY [US]; MARKOWITZ STEVEN M [US]; COMPTON DAVID L [US]; TRAYNOR HENRY G [US]; DULAK MICHAEL [US]


Patent No.: US7229609B2  Issued: 12/Jun/2007

Title: Diarylbutadiene-substituted methyltrialkylsilanes and photoprotective compositions comprised thereof

Applicant/Assignee: L'OREAL

Application No.: 10/995202   Filing Date: 24/Nov/2004

Abstract:

Novel 4,4-diarylbutadiene-substituted methyltrialkylsilanes having the structural formula (I): are useful sunscreens for UV-photoprotecting human skin against the damaging effects of UV-radiation, notably UV-A radiation.

Priority: FR20030050899 Applic. Date: 2003-11-25; US20030526988P Applic. Date: 2003-12-05

Inventor: RICHARD HERVE [FR]


Patent No.: US7229610B2  Issued: 12/Jun/2007

Title: Diarylbutadiene-substituted diorganopolysiloxanes and photoprotective compositions comprised thereof

Applicant/Assignee: L'OREAL

Application No.: 10/995226   Filing Date: 24/Nov/2004

Abstract:

Novel 4,4-diarylbutadiene-substituted diorganopolysiloxanes having the structural formulae (1) or (2): in which A is a radical of formula (3) below: are useful sunscreens for UV-photoprotecting human skin against the damaging effects of UV-radiation, notably UV-A radiation.

Priority: FR20030050900 Applic. Date: 2003-11-25; US20030526987P Applic. Date: 2003-12-05

Inventor: RICHARD HERVE [FR]


Patent No.: US7229648B2  Issued: 12/Jun/2007

Title: Homeopathic formulations useful for treating pain and/or inflammation

Applicant/Assignee:

Application No.: 10/797009   Filing Date: 11/Mar/2004

Abstract:

Homeopathic formulations (a) comprising tinctures and/or diluted extracts preferably subjected to potentization of at least 8 or 9 herbs selected from Bellis Perennis, Calendula Officinalis, Hamamelis Virginiana, Arnica Montana, Hypericum Perforatum, Aconitum Napellus, Ledum Palustre, Bryonia Alba and Ruta Graveolens

or (b) consisting of, as active ingredients, tinctures and/or diluted extracts subjected to potentization of 5, 6 or 7 herbs selected from Bellis Perennis, Calendula Officinalis, Hamamelis Virginiana, Arnica Montana, Hypericum Perforatum, Aconitum Napellus, Ledum Palustre, Bryonia Alba and Ruta Graveolens. The potentized homeopathics are in a penetrating base, preferably clear gel base. The homeopathic formulations are highly effective in treating or relieving pain and inflammation.

Also, a method of treating or relieving pain and inflammation by administering any of the homeopathic formulations of the invention to a subject, preferably a subject in need of such treatment or relief. Further, a method of making the homeopathic formulation by mixing the homeopathically prepared herbal active ingredients with a base, preferably a clear gel base.

Priority: US20030454308P Applic. Date: 2003-03-14

Inventor: DREYER LEE R [US]


Patent No.: US7232839B2  Issued: 19/Jun/2007

Title: Benzoisothiazolone compositions

Applicant/Assignee: L'OREAL

Application No.: 11/268565   Filing Date: 08/Nov/2005

Abstract:

A composition, suitable for topical application to the skin, containing at least one benzoisothiazolone of formula (I): Novel benzoisothiazolones of formula (I) and a method of caring for dry and/or mature skin.

Priority: FR20040052563 Applic. Date: 2004-11-08; US20040634984P Applic. Date: 2004-12-13

Inventor: LUCET-LEVANNIER KARINE [FR]; CAVEZZA ALEXANDRE [FR]; ERDELMEIER IRENE [FR]


Patent No.: US7232844B2  Issued: 19/Jun/2007

Title: Insect repellent compounds

Applicant/Assignee: E. I. DU PONT DE NEMOURS AND COMPANY

Application No.: 10/964415   Filing Date: 13/Oct/2004

Abstract:

Dihydronepetalactone, a minor natural constituent of the essential oil of catmints (Nepeta spp.) such as Nepeta cataria, has been identified as an effective insect repellent compound. Synthesis of dihydronepetalactone may be achieved by hydrogenation of nepetalactone, the major constituent of catmint essential oils. This compound, which also has fragrance properties, may be used commercially for its insect repellent properties.

Priority: US2003-392455 Applic. Date: 2003-03-19; US20020366147P Applic. Date: 2002-03-20

Inventor: HALLAHAN DAVID L [US]


Patent No.: US7234937B2  Issued: 26/Jun/2007

Title: Unified workstation for virtual craniofacial diagnosis, treatment planning and therapeutics

Applicant/Assignee: ORAMETRIX, INC

Application No.: 10/429123   Filing Date: 02/May/2003

Abstract:

An integrated system is described in which digital image data of a patient, obtained from a variety of image sources, including CT scanner, X-Ray, 2D or 3D scanners and color photographs, are combined into a common coordinate system to create a virtual three-dimensional patient model. Software tools are provided for manipulating the virtual patient model to simulation changes in position or orientation of craniofacial structures (e.g., jaw or teeth) and simulate their affect on the appearance of the patient. The simulation (which may be pure simulations or may be so-called "morphing" type simulations) enables a comprehensive approach to planning treatment for the patient. In one embodiment, the treatment may encompass orthodontic treatment. Similarly, surgical treatment plans can be created.

Data is extracted from the virtual patient model or simulations thereof for purposes of manufacture of customized therapeutic devices for any component of the craniofacial structures, e.g., orthodontic appliances.

Priority: US2003-340404 Applic. Date: 2003-01-09; US2000-560641 Applic. Date: 2000-04-28; US1999-452034 Applic. Date: 1999-11-30; US2001-835039 Applic. Date: 2001-04-13

Inventor: SACHDEVA ROHIT [US]; TANEJA SANJEEV [US]; SPORBERT PEER [DE]; GETTO PHILLIP [US]; MAETZEL STEPHAN [DE]; IMGRUND HANS [DE]; ABRAHAM CHARLES L [US]


Patent No.: US7235249B2  Issued: 26/Jun/2007

Title: Methods for regulating the condition of mammalian keratinous tissue via topical application of vitamin B6 compositions

Applicant/Assignee: THE PROCTER & GAMBLE COMPANY

Application No.: 10/109908   Filing Date: 28/Mar/2002

Abstract:

The present invention relates to methods for regulating the condition of mammalian keratinous tissue wherein the methods each comprise the step of topically applying to the keratinous tissue of a mammal needing such treatment, a safe and effective amount of a skin care composition comprising: a) a safe and effective amount of a vitamin B6 compound selected from the group consisting of pyridoxine, esters of pyridoxine, amines of pyridoxine, salts of pyridoxine and derivatives thereof, including pyridoxamine, pyridoxal, pyridoxal phosphate, and pyridoxic acid

b) a safe and effective amount of a skin care active selected from the group consisting of peptides, phytosterol, sugar amines, their derivatives, and combinations thereof

and c) a dermatologically acceptable carrier for the pyridoxine and the skin care active.

Priority:

Inventor: BISSETT DONALD LYNN [US]


Patent No.: US7235295B2  Issued: 26/Jun/2007

Title: Polymeric nanofibers for tissue engineering and drug delivery

Applicant/Assignee:

Application No.: 10/938493   Filing Date: 10/Sep/2004

Abstract:

Polymeric nanofibers have been developed which are useful in a variety of medical and other applications, such as filtration devices, medical prosthesis, scaffolds for tissue engineering, wound dressings, controlled drug delivery systems, cosmetic skin masks, and protective clothing. These can be formed of any of a variety of different polymers, either non-degradable or degradable. In a preferred embodiment demonstrated in the following examples, nanofibers are formed of biodegradable and non biodegradable polyphosphazenes, their blends with other polyphosphazenes or with organic, inorganic/organometallic polymers as well as composite nanofibers of polyphosphazenes with nanosized particles such as hydroxyapatites.

Priority: US20030501897P Applic. Date: 2003-09-10

Inventor: LAURENCIN CATO T [US]; NAIR LAKSHMI SREEDHARAN [US]; BHATTACHARYYA SUBHABRATA [US]; ALLCOCK HARRY R [US]; BENDER JARED D [US]; BROWN PAUL W [US]; GREISH YASER E [US]


Patent No.: US7238343B2  Issued: 03/Jul/2007

Title: Cosmetic method and composition for enhancing attractiveness

Applicant/Assignee: UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC UNILEVER HOME & PERSONAL CARE USA DIVISION OF CONOPCO, INC

Application No.: 10/733185   Filing Date: 11/Dec/2003

Abstract:

Hair removal, especially from armpits damages skin, for example by irritating it, and this can be exacerbated by the application of antiperspirants to control body odour generation. In the present invention, the deleterious effects of hair removal, eg shaving, and antiperspirancy can be ameliorated by employing antiperspirant compositions containing a natural oil and glycerol to a combined concentration of from 1.5 to 15% by weight and in a weight ratio of from 4:1 to 1:4.

Priority: GB20020029071 Applic. Date: 2002-12-13

Inventor: LEE ROBERT STANLEY [GB]; WATKINSON ALLAN [GB]


Patent No.: US7238680B2  Issued: 03/Jul/2007

Title: Topical compositions for veterinary uses

Applicant/Assignee:

Application No.: 10/161552   Filing Date: 03/Jun/2002

Abstract:

A method of treating a non-human dermatological disorder, wherein the method comprises topically administering to a non-human dermatological disorder a therapeutically effective amount of a topical composition containing: (1) an active component comprising at least one salicylate derivative

and (2) at least one pharmaceutically acceptable solubilizer.

Priority: US20010295093P Applic. Date: 2001-06-01; US20010298128P Applic. Date: 2001-06-13

Inventor: ROSEN STEVEN E [US]


Patent No.: US7238705B2  Issued: 03/Jul/2007

Title: Aporphine esters and their use in therapy

Applicant/Assignee: AXON BIOCHEMICALS B.V

Application No.: 10/344420   Filing Date: 15/Jul/2003

Abstract:

New aporphine derivatives are disclosed which have formula (I) and the physiologically acceptable salts thereof. Said derivatives may be used for the treatment of Parkinson's disease, hemicrania, restless legs syndrome (RLS), sexual dysfunction in men and women, hyperprolactemia and psychotic disorders, and/or evaluation of Parkinson's disease. Processes for the preparation of such derivatives are also disclosed.

Priority: SE20000002934 Applic. Date: 2000-08-17; WO2001SE01658 Applic. Date: 2001-07-20

Inventor: WIKSTROM HAKAN [NL]; DIJKSTRA DURK [NL]; CREMERS THOMAS [NL]; ANDREN PER ERIK [SE]; MARCHAIS SANDRINE [NL]; JURVA ULRIK [NL]


Patent No.: US7240708B2  Issued: 10/Jul/2007

Title: Pneumatic tire

Applicant/Assignee: MITSUBISHI GAS CHEMICAL COMPANY, INC

Application No.: 10/749409   Filing Date: 02/Jan/2004

Abstract:

A pneumatic tire comprising a skin layer which is formed by curing a polyurethane resin composition comprising a compound having active hydrogen atoms and an organic polyisocyanate compound, has an oxygen permeation coefficient at 23 DEG C. under a relative humidity of 60% of 2.0 ml.mm/m<2>.day.MPa or smaller and comprises 20% by weight or more of a skeleton structure represented by formula (1) is provided. Since the tire has the skin layer formed with the polyurethane resin composition and having an excellent barrier property to gases, the weight of the tire can be decreased, durability can be improved and quiet driving can be achieved while the internal pressure is retained even when the gas filling the tire is the air, and the tire is more economical than tires filled with nitrogen gas.

Unlike other tires using other materials having the barrier property to gases to decrease the weight, no adhesives are necessary for disposing the skin layer. Thus, the process can be simplified and the cost can be reduced in the production

Priority: JP20030001180 Applic. Date: 2003-01-07

Inventor: NOMURA TAKESHI [JP]; KOYAMA TAKESHI [JP]


Patent No.: US7241452B2  Issued: 10/Jul/2007

Title: Skin and hair care agents

Applicant/Assignee: STOCKHAUSEN GMBH & CO. KG

Application No.: 10/489596   Filing Date: 03/Aug/2004

Abstract:

The invention concerns aqueous agents for skin and hand care, compatible with the skin and having good cleansing effect. Said agents are characterized in that they contain 10 to 60 wt. % of one or more triglycerides, saturated or unsaturated fatty acids or mixtures thereof, 5 to 40 wt. % of at least a fatty alcohol ethoxylate, 10 to 65 wt. % of water, 0 to 30 wt. % of one or more abrasives, relative to the composition of the cleansing agents, and optionally one or more viscosity agents and other auxiliary agents, additives of active cosmetic agents.

Priority: WO2001EP10903 Applic. Date: 2001-09-20

Inventor: VEEGER MARCEL [DE]; KLOTZ ANDREAS [DE]; MAEHSE GERDA [DE]; HAEUSLER BEATRICE [DE]; FAENSEN KARIN [NL]


Patent No.: US7244417B2  Issued: 17/Jul/2007

Title: Stabilization of oxidation-sensitive or UV-sensitive active ingredients

Applicant/Assignee: BEIERSDORF AG

Application No.: 10/788607   Filing Date: 27/Feb/2004

Abstract:

The cosmetic or dermatological formulations of the invention include: (a) at least one oxidation-sensitive or UV-sensitive active ingredient, (b) at least one dialkyl naphthalate which is distinguished by the structural formula in which R<1 >and R<2>, independently of one another, are chosen from the group of branched and unbranched alkyl groups having 6 to 24 carbon atoms, and (c) at least one wax and/or one oil thickener. The present invention also includes methods of using the cosmetic or dermatological formulations.

Priority: DE20011041477 Applic. Date: 2001-08-29; WO2002EP09375 Applic. Date: 2002-08-22

Inventor: WENDEL VOLKER [DE]; GOEPPEL ANJA [DE]


Patent No.: US7244447B2  Issued: 17/Jul/2007

Title: Transdermal administration of nonsteroidal anti-inflammatory drugs using hydroxide-releasing agents as permeation enhancers

Applicant/Assignee: DERMATRENDS, INC

Application No.: 10/631539   Filing Date: 30/Jul/2003

Abstract:

A method is provided for increasing the permeability of skin or mucosal tissue to transdermally administered nonsteroidal anti-inflammatory drugs (NSAIDs). The method involves use of a specified amount of a hydroxide-releasing agent, the amount optimized to increase the flux of the NSAID through a body surface while minimizing the likelihood of skin damage, irritation or sensitization. Formulations and drug delivery systems for co-administering a hydroxide-releasing agent with an NSAID are provided as well.

Priority: US2000-737830 Applic. Date: 2000-12-14; US2000-569889 Applic. Date: 2000-05-11; US1999-465098 Applic. Date: 1999-12-16

Inventor: HSU TSUNG-MIN [US]; LUO ERIC C [US]


Patent No.: US7252830B2  Issued: 07/Aug/2007

Title: Moisturizing compositions

Applicant/Assignee: THE GILLETTE COMPANY

Application No.: 10/679738   Filing Date: 06/Oct/2003

Abstract:

Moisturizing compositions containing bilayered vesicles, e.g., microvesicles, are provided. In some implementations, the vesicles include an ethoxylated polyol ester of a fatty acid, a sterol, and a long chain fatty alcohol.

Priority:

Inventor: NOVIKOV ALEXANDER [US]; THONG STEPHEN [US]; O'GRADY JANET KELLEY [US]


Patent No.: US7255853B2  Issued: 14/Aug/2007

Title: Photoprotective cosmetic compositions containing aromatic amide, sulphonamide or carbamate derivatives of acrylonitrile and novel aromatic amide, sulphonamide or carbamate derivatives of acrylonitrile

Applicant/Assignee: L'OREAL

Application No.: 10/804128   Filing Date: 19/Mar/2004

Abstract:

Cosmetic compositions for topical use for protecting the skin and the hair, containing, in a cosmetically acceptable support, at least one compound of formula (1) or (2) in which X1 represents R3-(C-O)-, R3-SO2- or R3-O-(C-O)-, X2 represents -(C-O)-R'3-(C-O), -SO2-R'3-SO2- or -(C-O)-O-R'3-O-(C-O)-, Y represents -(C-O)-R4 or -SO2R5, R2 represents a C1-8 alkyl group, n is 0, 1 or 2, R3 represents C1-30 alkyl or C3-30 alkenyl, R'3 represents a single bond or a divalent C1-30 alkylene or C3-30 alkenylene radical, R4 represents -OR6 or -NHR6, R5 represents C1-30 alkyl or a phenyl nucleus, R6 represents C1-30 alkyl or C3-30 alkenyl, and novel compounds of formula (2).

Priority: FR20010008092 Applic. Date: 2001-06-20; US2002-174485 Applic. Date: 2002-06-19

Inventor: RICHARD HERVE [FR]; LUPPI BERNADETTE [FR]


Patent No.: US7256183B2  Issued: 14/Aug/2007

Title: Method for treating or preventing inflammatory diseases

Applicant/Assignee: INSPIRE PHARMACEUTICALS, INC

Application No.: 10/290213   Filing Date: 06/Nov/2002

Abstract:

The present invention provides a method of preventing or treating an inflammatory disease, including but not limited to, sinusitis, rhinitis, conjunctivitis, asthma, dermatitis, inflammatory bowel disease, inflammatory collagen vascular diseases, glomerulonephritis, inflammatory skin diseases, and sarcoidosis. The method comprises administrating to a subject a pharmaceutical formulation comprising a nucleotide receptor agonist, such as nucleoside diphosphate, nucleoside triphosphate, or dinucleoside polyphosphate, according to general formula Ia, Ib, IIa, IIb, or III. Preferred indications of the present invention are perennial allergic rhinitis, seasonal allergic rhinitis, infectious allergic rhinitis, and allergic conjunctivitis.

Priority: US20010337828P Applic. Date: 2001-11-06

Inventor: PETERSON WARD M [US]; YERXA BENJAMIN R [US]


Patent No.: US7258871B2  Issued: 21/Aug/2007

Title: Combination of a transdermal therapeutic system and an oral and/or parenteral preparation containing dopamine agonists for the treatment of dopaminergic disease states

Applicant/Assignee: NEUROBIOTEC GMBH

Application No.: 10/362182   Filing Date: 03/Jul/2003

Abstract:

The invention relates to the use of a dopamine agonist in the form of an agent consisting of at least two spatially discrete compositions, of which one is a transdermal therapeutic system (TTS) containing the dopaminergic agent and another one or more are preparations for oral and/or parenteral application containing that same dopaminergic agent for the treatment of dopaminergically treatable diseases with the following elements: a) the TTS is continuously applied, b) within the duration of application in a) the composition for oral or parenteral dosage is administered.

Priority: DE20001053397 Applic. Date: 2000-10-20; WO2001EP09826 Applic. Date: 2001-08-24

Inventor: HOROWSKI REINHARD [DE]; TACK JOHANNES [DE]


Patent No.: US7262179B2  Issued: 28/Aug/2007

Title: Wound care compositions

Applicant/Assignee: BRISTOL-MYERS SQUIBB COMPANY

Application No.: 10/447062   Filing Date: 28/May/2003

Abstract:

Compositions for the treatment of wounds and skin injuries are described. The compositions, which include gellan gum, increases in viscosity once applied to the wound to form an immobile gel. The composition may be in sprayable form or dispersed in an aqueous solution. Methods of making and using the compositions are also described.

Priority:

Inventor: COURT ANDREW D [GB]; KERSHAW DAVID D [GB]


Patent No.: US7262224B2  Issued: 28/Aug/2007

Title: Cosmetic rejuvenating and healing product, method of its manufacture and uses thereof

Applicant/Assignee: HANNA ISUL SKIN THERAPY, INC

Application No.: 10/359963   Filing Date: 06/Feb/2003

Abstract:

A cosmetic composition is shown for rejuvenating the appearance of skin with reduced or minimal potential for skin irritation, in the form of a lotion or cream which includes as a major component aloe vera as well as vitamins A, B, C, D and E.

Priority: US2000-723884 Applic. Date: 2000-11-28; US19990168257P Applic. Date: 1999-11-30

Inventor: CHONG MYONG HUN [US]


Patent No.: US7264797B2  Issued: 04/Sep/2007

Title: Cosmetic composition

Applicant/Assignee: UNILEVER HOME & PERSONAL CARE USA UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC

Application No.: 10/748945   Filing Date: 29/Dec/2003

Abstract:

A composition comprising an antiperspirant or deodorant active and which is substantially free of alcohol and has a viscosity of less than 100 centipoise and a contact angle less than 90 DEG . A product comprising the composition marketed in a porous dome applicator.

Priority:

Inventor: CHEN LIANG BIN [US]; BREWSTER DAVID A [US]


Patent No.: US7264933B2  Issued: 04/Sep/2007

Title: Methods to identify biologically active agents and synergistic combinations

Applicant/Assignee: SYNERGY BIOSYSTEMS LTD

Application No.: 10/807811   Filing Date: 24/Mar/2004

Abstract:

Methods are described using a particular type of assay system, the Multi-Pathway High Throughput Assay, in conjunction with a novel experimental strategy, whereby repeated cycles of experiments result in the identification of the most effective synergistic combinations of potential active agents from a library of materials. The novel experimental strategy not only requires far fewer total experiments than would be required using conventional discovery strategies but also maximizes the probability of finding highly synergistic combinations through the principle of multiple-pathway intervention.

Priority: US20030457859P Applic. Date: 2003-03-26; US20030457860P Applic. Date: 2003-03-26; US20030457861P Applic. Date: 2003-03-26; US20030483564P Applic. Date: 2003-06-28

Inventor: SCOTT IAN R [US]


Patent No.: US7267829B2  Issued: 11/Sep/2007

Title: Compositions for rapid and non-irritating transdermal delivery of pharmaceutically active agents and methods for formulating such compositions and delivery thereof

Applicant/Assignee: TRANSDERMAL TECHNOLOGIES, INC

Application No.: 10/831416   Filing Date: 23/Apr/2004

Abstract:

A transdermal delivery system (TDS)for use in treatment of living bodies may be applied as an open (liquid, gel) or closed (patch) article. The TDS is composed of a particular active agent which dictates an associated selection of certain solvents, solvent modifiers, solute modifiers and skin stabilizers with which the medicament forms a true solution that rapidly crosses the skin barrier. The associated selection of the particular solvents, solvent modifiers, solute modifiers and skin stabilizers is based on a balancing of the molecular properties of all the components against the molecular properties of all the components plus the particular active agent. The TDS may also include a source of cellular energy to induce CAMP or cGMP. The TDS improves delivery of active agents having a molecular weight greater than 340 Daltons and increases dosage above 0.25 mg/day for such active agents.

Priority: US2002-074497 Applic. Date: 2002-02-11; US2000-381095 Applic. Date: 2000-05-11; WO1999US15297 Applic. Date: 1999-07-07; US19980091910P Applic. Date: 1998-07-07

Inventor: KIRBY KENNETH B [US]; PETTERSSON BERNO [US]


Patent No.: US7268120B1  Issued: 11/Sep/2007

Title: Methods for treating cancer using cytokine-expressing polynucleotides

Applicant/Assignee: VICAL INCORPORATED

Application No.: 09/557907   Filing Date: 21/Apr/2000

Abstract:

The present invention provides a pharmaceutical composition, comprising a non-infectious, non-integrating polynucleotide construct comprising a polynucleotide encoding an interferon omega and one or more cationic compounds. The present invention also provides methods of treating cancer in a mammal, comprising administering into a muscle of the mammal a non-infectious, non-integrating DNA polynucleotide construct comprising a polynucleotide encoding a cytokine. In addition, the present invention also relates to the methodology for selective transfection of malignant cells with polynucleotides expressing therapeutic or prophylactic molecules in intra-cavity tumor bearing mammals. More specifically, the present invention provides a methodology for the suppression of an intra-cavity dissemination of malignant cells, such as intraperitoneal dissemination. Furthermore, the invention relates to compositions and methods to deliver polynucleotides encoding polypeptides to vertebrate cells in vivo, where the composition comprises an aqueous solution of sodium phosphate.

Priority: US1998-196313 Applic. Date: 1998-11-20; US19970067087P Applic. Date: 1997-11-20; US19980079914P Applic. Date: 1998-03-30; US19980100820P Applic. Date: 1998-09-15

Inventor: HORTON HOLLY [US]; PARKER SUEZANNE [US]; MANTHORPE MARSTON [US]; FELGNER PHILIP L [US]; HARTIKKA JUKKA [US]


Patent No.: US7268148B2  Issued: 11/Sep/2007

Title: Compositions and methods for use against acne-induced inflammation and dermal matrix-degrading enzymes

Applicant/Assignee: REGENTS OF THE UNIVERSITY OF MICHIGAN

Application No.: 11/169072   Filing Date: 27/Jun/2005

Abstract:

Acne-affected skin has been found to be accompanied by the presence of matrix-degrading enzymes such as MMPs and neutrophil elastase, induction of neutrophils, and a reduction in procollagen biosynthesis. This invention treats scarring and inflammation accompanying acne by administering, topically or systemically, at least one of (i) an inhibitor of the matrix degrading enzymes and (ii) a cytokine inhibitor that alleviates inflammation and thus also alleviate neutrophil infiltration. Alleviating the matrix degradation and renormalizing procollagen biosynthesis allows for reduced inflammation and better natural repair of acne-affected skin. Inhibiting cytokines alleviates induction of MMPs in resident skin cells, and also alleviates inflammation with its concommitant induction of neutrophils from the blood stream bringing MMPs and elastase into the acne lesion.

Dimishing the presence of matrix-degrading enzymes in the acne lesion reduces imperfect repair of the skin and thus decreases scarring in acne-affected skin.

Priority: US2000-576597 Applic. Date: 2000-05-22; US19990134984P Applic. Date: 1999-05-20

Inventor: VOORHEES JOHN J [US]; FISHER GARY J [US]; KANG SEWON [US]


Patent No.: US7268177B2  Issued: 11/Sep/2007

Title: Thermoplastic Elastomer-Based Solid Emulsions

Applicant/Assignee: LABORATOIRES URGO

Application No.: 10/514251   Filing Date: 15/Nov/2004

Abstract:

The present invention relates to novel solid emulsions, characterised in that they comprise a thermoplastic elastomer of poly(styrene-olefin-styrene) block copolymer type, an aqueous phase, an oily phase and an amphiphilic copolymer. The invention also relates to the use of these novel solid emulsions notably for the preparation of products for medical, dermatological or cosmetological purposes which come into contact with a wound, skin or mucous membranes.

Priority: WO2003FR01216 Applic. Date: 2003-04-16; FR20020004780 Applic. Date: 2002-04-17

Inventor: AUGUSTE STEPHANE [FR]; DESMAISON NADEGE [FR]


Patent No.: US7268205B2  Issued: 11/Sep/2007

Title: Medical Devices and Applications of Polyhydroxyalkanoate Polymers

Applicant/Assignee: METABOLIX, INC

Application No.: 11/623593   Filing Date: 16/Jan/2007

Abstract:

Devices formed of or including biocompatible polyhydroxyalkanoates are provided with controlled degradation rates, preferably less than one year under physiological conditions. Preferred devices include sutures, suture fasteners, meniscus repair devices, rivets, tacks, staples, screws (including interference screws), bone plates and bone plating systems, surgical mesh, repair patches, slings, cardiovascular patches, orthopedic pins (including bone filling augmentation material), adhesion barriers, stents, guided tissue repair/regeneration devices, articular cartilage repair devices, nerve guides, tendon repair devices, atrial septal defect repair devices, pericardial patches, bulking and filling agents, vein valves, bone marrow scaffolds, meniscus regeneration devices, ligament and tendon grafts, ocular cell implants, spinal fusion cages, skin substitutes, dural substitutes,

bone graft substitutes, bone dowels, wound dressings, and hemostats. The polyhydroxyalkanoates can contain additives, be formed of mixtures of monomers or include pendant groups or modifications in their backbones, or can be chemically modified, all to alter the degradation rates. The polyhydroxyalkanoate compositions also provide favorable mechanical properties, biocompatibility, and degradation times within desirable time frames under physiological conditions.

Priority: US2004-020896 Applic. Date: 2004-12-22; US2002-136499 Applic. Date: 2002-05-01; US2000-535146 Applic. Date: 2000-03-24; US19990142238P Applic. Date: 1999-07-02; US19990126180P Applic. Date: 1999-03-25

Inventor: WILLIAMS SIMON F [US]; MARTIN DAVID P [US]; SKRALY FRANK A [US]


Patent No.: US7270828B2  Issued: 18/Sep/2007

Title: Personal care composition comprising hydrophobic gel

Applicant/Assignee: THE PROCTER & GAMBLE COMPANY

Application No.: 10/740254   Filing Date: 18/Dec/2003

Abstract:

Disclosed is a polyol-in-silicone emulsion consisting essentially of: (i) an alkyl dimethicone copolyol having an HLB of from about 4 to about 6, and a molecular weight of from about 10,000 to about 20,000, wherein the alkyl group is made of about 10 to about 22 carbons

and (ii) a polyol, wherein the weight ratio of the alkyl dimethicone copolyol to the polyol is from about 100:1 to about 2:8

methods to make such a polyol-in-silicone emulsion, as well as an anhydrous personal care composition comprising by weight: (a) from about 0.01% to about 15% of an alkyl dimethicone copolyol having an HLB of about 4-6, and a molecular weight of from about 10,000 to about 20,000, wherein the alkyl group is made of about 10 to about 22 carbons

(b) from about 0.01% to about 35% of a polyol, wherein the weight ratio of the alkyl dimethicone copolyol to the polyol is from about 100:1 to about 2:8

and wherein the composition is substantially free of water.

Priority: WO2001US19702 Applic. Date: 2001-06-20

Inventor: MASUDA HISATOSHI [JP]; ISHIGAMI MAYU [JP]; DECKNER GEORGE ENDEL [US]


Patent No.: US7276230B2  Issued: 02/Oct/2007

Title: Sunscreen compounds and compositions containing same and methods for use thereof

Applicant/Assignee: AVON PRODUCTS, INC

Application No.: 10/744365   Filing Date: 23/Dec/2003

Abstract:

There is provided a photostable and synergistically enhanced topical sunscreen composition that provides increased substantivity, waterproofness, sweat resistance and rub off resistance. There is further provided methods of enhancing the photostability of a sunscreen active in a topical sunscreen composition, synergistically enhancing the UV absorbance of a topical sunscreen composition having a sunscreen active, and enhancing the substantivity, waterproofness, sweat resistance and rub off resistance in a topical sunscreen composition.

The preferred compositions and methods have a sunscreen active, a cosmetically acceptable vehicle, and novel 2-substituted-3,3-diaryl-2-propenoic acid derivatives with [A] a C16 to C50 straight or branched chain, substituted or un-substituted, conjugated or non-conjugated hydrocarbon, or [B] a siloxane, polysiloxane, organo-modified polysiloxane residue, a group represented by the formula R<10>[Si(R<10>)2]n- and R<11 >which is a silicone residue derived from a silicone represented by the formula R<11>OH having a molecular weight up to about 30,000, wherein each R<10 >is independently selected from the group consisting of alkyl, alkoxy, aryl and aryloxy and n is from 1 to about 500.

Priority:

Inventor: GONZALEZ ANTHONY D [US]; PECHKO ANDREW H [US]; ANDERSON GLEN T [US]; KALAFSKY ROBERT E [US]


Patent No.: US7276256B2  Issued: 02/Oct/2007

Title: Cosmetic or healing gel for application to the human skin

Applicant/Assignee: BIOFARM S. R. L BIOFARMITALIA S.P.A

Application No.: 10/778102   Filing Date: 17/Feb/2004

Abstract:

A gel formed from an intimate mixture of polyvinyl alcohol, an alkaline or alkaline earth metal borate, water and an alginate and/or a carrageenan, having cryogenic characteristics, substances with cosmetic and/or pharmacological characteristics being easily dispersible in said gel, to be released slowly when the gel is applied to the human skin.

Priority: IT2003MI00343 Applic. Date: 2003-02-26

Inventor: PINNA FAUSTO [IT]; PINNA MARCO [IT]


Patent No.: US7276494B2  Issued: 02/Oct/2007

Title: Photosensitisers

Applicant/Assignee: PHOTOPHARMICA LIMITED

Application No.: 10/393783   Filing Date: 21/Mar/2003

Abstract:

A compound for use as a photosensitiser in PDT, in photochemical internalisation in the production of a cancer vaccine or in the diagnosis or detection of medical conditions, the compound having a photosensitising chromophoric system, a sulphonamido functionality and a carboxy functionality. The compounds used in the present invention are photosensitisers in PDT in vivo, and show phototoxic activity in vitro. The compounds are used to treat pre-cancerous conditions, cancer, ophthalmological disease, vascular problems, arteriosclerosis and restenosis and autoimmune diseases, skin diseases and other benign conditions, and for anti-microbial treatments.

Priority: GB20000023367 Applic. Date: 2000-09-23; WO2001GB04224 Applic. Date: 2001-09-21

Inventor: BROWN STANLEY BEAMES [GB]; BELL ANDREA LUCILLE [GB]; GRIFFITHS JOHN [GB]; SCHOFIELD JACK [GB]


Patent No.: US7282197B2  Issued: 16/Oct/2007

Title: Antiperspirant gel

Applicant/Assignee: BEIERSDORF AG

Application No.: 10/892159   Filing Date: 16/Jul/2004

Abstract:

A cosmetic or dermatological composition for preventing excessive odor and sweat secretion by skin, comprising an optically translucent to transparent, substantially alcohol-free oil-in-water type emulsion gel which comprises a polyethoxylated and/or a polypropoxylated O/W emulsifier, a polyol and a antiperspirant. This abstract is neither intended to define the invention disclosed in this specification nor intended to limit the scope of the invention in any way.

Priority: DE20031032928 Applic. Date: 2003-07-19

Inventor: DIEC KHIET HIEN [DE]; KUX ULRICH [DE]


Patent No.: US7282224B1  Issued: 16/Oct/2007

Title: Pain relief composition

Applicant/Assignee: GUTHY-RENKER CORPORATION

Application No.: 11/450648   Filing Date: 09/Jun/2006

Abstract:

Disclosed is a pain relief composition comprising an effective amount of a nerve inhibiting component, including capsaicin, a capsaicinoid or a capsaicin analogue, which numbs or inhibits the nerve endings that signal pain, in combination with at least one of the following: an effective amount of an inflammation control component which is designed to reduce immediate pain and discourage future pain in the joints and muscles

an effective amount of a cooling component

an effective amount of a heat minimizing or blocking component

an effective amount of a circulation increasing component which effectuates better penetration of the actives to the skin and nerves

and an effective amount of a soothing and anti-inflammatory complex for the joints and/or muscles comprising Glucosamine sulfate or HCl, Zingiber officiniale (Ginger Root) extract, Methyl sulfonylmethane (MSM), Polygonum cuspidatum (Mexican Bamboo) extract, Aloe barbadensis leaf, and Salix alba (white willow) bark extract. Additionally, the composition includes an encapsulation or entrapment system for a timed release delivery.

Priority:

Inventor: ROEDERER JOY E [US]


Patent No.: US7282522B2  Issued: 16/Oct/2007

Title: Hydroxamic acid derivatives and the method for preparing thereof

Applicant/Assignee: AMOREPACIFIC CORPORATION

Application No.: 10/595124   Filing Date: 26/Aug/2004

Abstract:

The present invention provides hydroxamic acid derivatives which have anti-aging efficacy and a method for preparation thereof. It is further provided skin-care external compositions for preventing skin aging, containing the hydroxamic acid derivatives represented by the formula (I) as an active ingredient.

Priority: KR20030059177 Applic. Date: 2003-08-26; KR20040020401 Applic. Date: 2004-03-25; KR20040054886 Applic. Date: 2004-07-14; WO2004KR02143 Applic. Date: 2004-08-26

Inventor: RHO HO-SIK [KR]; BAEK HEUNG-SOO [KR]; KIM SU-JONG [KR]; KIM SU-NAM [KR]; CHAE BYUNG-GEUN [KR]; LEE BYOUNG-SEOK [KR]; KIM BAE-HWAN [KR]; CHOI GYU-HO [KR]; SON EUI-DONG [KR]; LEE HAE-KWANG [KR]; LEE HYE-WON [KR]; CHO JUN-CHEOL [KR]; KIM DUCK-HEE [KR]; CHANG IH-SEOP [KR]; LEE OK-SUB [KR]


Patent No.: US7285521B2  Issued: 23/Oct/2007

Title: Detergent composition comprising predominantly soap and palygorskite clay

Applicant/Assignee: UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC

Application No.: 11/051775   Filing Date: 04/Feb/2005

Abstract:

The invention relates to a synergistic detergent composition capable of reducing oiliness or greasiness of the skin and also reduce post wash re-accumulation of sebum on the skin. It is particularly preferred to formulate the composition as a wash off product by incorporating a clay belonging to the hormite group of the 2:1 type of clay minerals, and having an inverted ribbon configuration.

Priority: IN2004MU00138 Applic. Date: 2004-02-06

Inventor: CHAKRABARTY DEBOJIT [IN]; PARTE ANANT KONDIRAM [IN]; PAWAR YASHODHARA [IN]


Patent No.: US7285570B2  Issued: 23/Oct/2007

Title: Compositions and methods for regulating mammalian keratinous tissue

Applicant/Assignee: THE PROCTER & GAMBLE COMPANY

Application No.: 10/418594   Filing Date: 17/Apr/2003

Abstract:

Skin care compositions and methods for regulating the condition of mammalian keratinous tissue containg an effective amount of a dialkanoyl hydroxyproline compound and a second skin care compound selected from hexamidine compounds, sugar amine compounds and their combination. These compositions may be either an emulsion or a solution wherin the dialkanoyl hydroxyproline compound may be converted to its salt for incorporation into the aqueous phase of a compositions.

Priority:

Inventor: ROBINSON LARRY RICHARD [US]; TANNER PAUL ROBERT [US]


Patent No.: US7285638B2  Issued: 23/Oct/2007

Title: Method of obtaining biologically active collagen from skins of the salmonidae fish

Applicant/Assignee: 3-HELISA SP. 2 0.0

Application No.: 10/686249   Filing Date: 09/Aug/2004

Abstract:

The method of obtaining collagen as above, is characterized by this, that the process of cleaning the skins is done manually using tools made of natural materials such as glass and wood to remove from the skins scales, skills and meat tissue so prepared raw material is placed in a solution of lactic acid of 0.1 to 1.5% concentration, obtaining hydration of collagen contained in the skins. The hydration process is carried out in glass containers, in the temperature from 15 to 20 DEG C., for 24 to 48 hours, conducting a running visual control of the process. Next follows an operation of filtration using silk filters of increasing density. By repeated filtering the cell elements, pigments and remains of the acid solution are removed from collagen. The natural silk filters have a structure similar to the structure of collagen, which prevents damage to the collagen structure.

Priority: PL20020356650 Applic. Date: 2002-10-15

Inventor: PRZYBYLSKI JOZEF EDWARD [PL]; SIEMASZKO-PRZYBYLSKA KRYSTYNA [PL]


Patent No.: US7288267B2  Issued: 30/Oct/2007

Title: Bioadhesive nanoparticulate compositions having cationic surface stabilizers

Applicant/Assignee: ELAN PHARMA INTERNATIONAL LTD

Application No.: 10/004808   Filing Date: 07/Dec/2001

Abstract:

Bioadhesive nanoparticulate compositions, comprising active agent particles and one or more cationic surface stabilizers, are described. The cationic surface stabilizers prevent aggregation of the nanoparticles and increase bioadhesion of the nanoparticles to biological substrates, such as an insect, teeth, bone, nails, chitin, feathers, scales, mucous, skin, hair, plant tissue, etc. The particles may consist of pharmacologically active compounds (e.g., drug compounds for human or veterinary use), agricultural chemicals (pesticides, herbicides, fertilizers, and the like), cosmetic agents, consumer products (coloring agents, flavors, or fragrances), or other materials which function by interacting with biological substrates. In addition, the invention relates to methods of preparing and using such bioadhesive nanoparticulate compositions.

Priority: US1999-414159 Applic. Date: 1999-10-08

Inventor: BOSCH H WILLIAM [US]; COOPER EUGENE R [US]; MCGURK SIMON L [US]


Patent No.: US7291322B2  Issued: 06/Nov/2007

Title: Photoprotecting/cosmetic compositions comprising benzotriazole and bis-resorcinyltriazine

Applicant/Assignee: SOCIETE L'OREAL, S.A L'OREAL

Application No.: 11/529618   Filing Date: 29/Sep/2006

Abstract:

Topically applicable sunscreen/cosmetic compositions suited for the improved photoprotection of human skin and/or hair against the damaging effects of UV-irradiation, particularly solar radiation, comprise an effective SPF-maintaining and water remanence-enhancing amount of intimate admixture of (a) at least one benzotriazole first sunscreen compound and (b) at least one bis-resorcinyltriazine second sunscreen compound, formulated into (c) a topically applicable, cosmetically acceptable vehicle, diluent or carrier therefor.

Priority: FR19990001729 Applic. Date: 1999-02-12; US2004-855350 Applic. Date: 2004-05-28; US2001-927488 Applic. Date: 2001-08-13; WO2000FR00257 Applic. Date: 2000-02-03

Inventor: CANDAU DIDIER [FR]


Patent No.: US7294352B2  Issued: 13/Nov/2007

Title: Matrix protein composition for treating inflammation

Applicant/Assignee: BIORA BIOEX AB

Application No.: 10/698618   Filing Date: 30/Oct/2003

Abstract:

Active enamel substances may be used for the preparation of a pharmaceutical or cosmetic composition for healing of a wound, improving healing of a wound, soft tissue regeneration or repair, or for preventing or treating infection or inflammation.

Priority: DK19980000270 Applic. Date: 1998-02-27; DK19980001328 Applic. Date: 1998-10-16; US2002-156300 Applic. Date: 2002-05-28; US1999-258613 Applic. Date: 1999-02-26; US19980081551P Applic. Date: 1998-04-13

Inventor: GESTRELIUS STINA [SE]; HAMMARSTROEM LARS [SE]; LYNGSTADAAS PETTER [NO]; ANDERSSON CHRISTER [SE]; SLABY IVAN [SE]; HAMMARGREN TOMAS [SE]


Patent No.: US7295867B2  Issued: 13/Nov/2007

Title: Signal processing for measurement of physiological analytes

Applicant/Assignee: CYGNUS, INC ANIMAS CORPORATION

Application No.: 10/366434   Filing Date: 12/Feb/2003

Abstract:

A method is provided for continually or continuously measuring the concentration of target chemical analytes present in a biological system, and processing analyte-specific signals to obtain a measurement value that is closely correlated with the concentration of the target chemical analyte in the biological system. One important application of the invention involves a method for signal processing in a system for monitoring blood glucose values.

Priority: US2001-794783 Applic. Date: 2001-02-27; US1999-309728 Applic. Date: 1999-05-11; US19980085344P Applic. Date: 1998-05-13

Inventor: BERNER BRET [US]; DUNN TIMOTHY C [US]; FARINAS KATHLEEN C [US]; GARRISON MICHAEL D [US]; KURNIK RONALD T [US]; LESHO MATTHEW J [US]; POTTS RUSSELL O [US]; TAMADA JANET A [US]; TIERNEY MICHAEL J [US]


Patent No.: US7297678B2  Issued: 20/Nov/2007

Title: Use of repeat sequence protein polymers in personal care compositions

Applicant/Assignee: GENENCOR INTERNATIONAL, INC

Application No.: 10/800179   Filing Date: 12/Mar/2004

Abstract:

A personal care composition is provided and includes an effective amount of a repeat sequence protein polymer. The personal care composition may be a hair care composition, a skin care composition, a nail care composition, a cosmetic composition, or an over-the-counter pharmaceutical composition.

Priority: US20030454077P Applic. Date: 2003-03-12

Inventor: KUMAR MANOJ [US]; CUEVAS WILLIAM A [US]


Patent No.: US7300675B2  Issued: 27/Nov/2007

Title: Lipolysis stimulator

Applicant/Assignee: KAO CORPORATION

Application No.: 10/900102   Filing Date: 28/Jul/2004

Abstract:

A lipolysis stimulator and a slimming agent which stimulate or facilitate lipolysis of accumulated adipose tissue, to thereby exert the body slimming effect. The lipolysis stimulator or the slimming agent of the present invention contains as an active ingredient any form of a plant or an extract thereof, the plant being selected from among common juniper, togenashi, rosehip, areca, polygala root, plantago herb, calumba, zuikorodoku, garden nasturtium, kidachiumanosuzukusa, bayberry, cogon grass, kohon, shoyokanzo, Japanese white birch, tanjin, kikubafuro, white mustard, common sunflower, ground ivy, Chinese wolfberry, Japanese pagota tree, sennenken, common fig, kankatto, Chinese hibiscus, usubaakaza, fenugreek, English walnut, sozuku, koniwa-zakura, gardenia, shima-kan-giku, akamino-akane, futaba-mugura, karoou, schizonepeta spike, purslane, karabyakushi, and prostrate knotweed.

Priority: JP20030203095 Applic. Date: 2003-07-29; JP20040156535 Applic. Date: 2004-05-26

Inventor: MORI SHINOBU [JP]; KUSUOKU HIROSHI [JP]; SATO MAYUMI [JP]


Patent No.: US7300678B2  Issued: 27/Nov/2007

Title: Method for obtaining an active principle with immediate skin-tightening effect and resulting active principle

Applicant/Assignee: SOCIETE INDUSTRIELLE LIMOUSINE D'APPLICATION BIOLOGIQUE (SILAB)

Application No.: 10/398170   Filing Date: 24/Oct/2003

Abstract:

The invention concerns an active principle with instant skin-tightening effect useable in cosmetics, the method for obtaining same and compositions comprising said active principle. The source material consists of a white almond press cake.

Priority: FR20000012561 Applic. Date: 2000-10-02; WO2001FR02995 Applic. Date: 2001-09-27

Inventor: PAUFIQUE JEAN-JACQUES [FR]


Patent No.: US7300926B2  Issued: 27/Nov/2007

Title: Steroidal quinols and their use for estrogen replacement therapy

Applicant/Assignee: UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER AT FORT WORTH

Application No.: 10/666191   Filing Date: 17/Sep/2003

Abstract:

The present invention relates to novel estrogen-related steroidal quinols and their use as drugs for estrogen replacement therapy. The quinols of the present invention provide improved physicochemical properties, increased bioavailability, and improved distribution into tissues, bone, in the cardiovascular system, and in the CNS (central nervous system) with only a slight estrogenic action or no estrogenic action in the uterus. The compounds are suitable for the production of pharmaceutical agents for use in numerous indications (for example, estrogen replacement therapy, prevention and treatment of osteoporosis).

Priority: US2003-405413 Applic. Date: 2003-04-01; US20020369589P Applic. Date: 2002-04-01

Inventor: PROKAI LASZLO [US]; PROKAI KATALIN [US]; SIMPKINS JAMES [US]


Patent No.: US7303774B2  Issued: 04/Dec/2007

Title: Relax cosmetic having a temperature effect

Applicant/Assignee: COTY B.V

Application No.: 10/741335   Filing Date: 19/Dec/2003

Abstract:

The present invention relates to new cosmetic relax preparations bringing about changing temperature effects on the skin. Said cosmetic contains 0.1-10% by weight of an extract from Papaveraceae and 0.1-10% by weight of an extract from the overground parts of Menthae, along with 80-99.8% by weight of cosmetic auxiliaries, carrier substances, active agents or mixtures thereof.

Priority: DE20021061815 Applic. Date: 2002-12-19

Inventor: GOLZ-BERNER KARIN [MC]; ZASTROW LEONHARD [MC]


Patent No.: US7311925B2  Issued: 25/Dec/2007

Title: Methods and compositions for blocking microbial adherence to eukaryotic cells

Applicant/Assignee:

Application No.: 10/053299   Filing Date: 17/Jan/2002

Abstract:

A method of blocking microbial adherence to a eukaryotic cell surface in a mammal by applying a pharmacologically acceptable composition containing at least one compound selected from the group consisting of isoleucine, an active isomer thereof, and an active analog thereof, to said surface in a microbial blocking quantity. Also, compositions for achieving the above blocking of microbial adherence.

Priority: US20010263049P Applic. Date: 2001-01-22

Inventor: ZASLOFF MICHAEL A [US]; ANDERSON GLENN M [US]


Patent No.: US7312198B2  Issued: 25/Dec/2007

Title: Protein compositions for promoting wound healing and skin regeneration

Applicant/Assignee: ESSENTIAL SKINCARE, LLC

Application No.: 11/430574   Filing Date: 09/May/2006

Abstract:

Methods for stimulating proliferation and inhibiting death of cells in the epidermis and dermis of wounded and non-wounded as well as transplanted mammalian skin and transplanted skin cell suspensions are described. The methods include the steps of administering to an area of wounded or non-wounded skin therapeutically effective amounts of alpha1-antitrypsin, alkaline phosphatase (such as placental alkaline phosphatase), transferrin, and alpha1-acid glycoprotein in compositions that contain at least two of these proteins, or their active derivatives, as the major active components. The compositions can be administered topically and/or by injection, or both.

The invention also provides regimens for restoring or maintaining the strength and thickness of wounded, non-wounded and transplanted skin as well as developing new skin from skin cell suspensions comprising periodically administering one or more compositions topically and/or by injection.

Priority: US20050698321P Applic. Date: 2005-07-12

Inventor: KISS ZOLTAN [US]

US Patents Granted in 2008
 
US Patents Granted in 2006
...or use our Search Engine to
search for patent documents by
number.
Search for anything. Simply
type the words in the box..
Clck to enlarge and view details
US PATENTS IN ACTIVES FOR SKIN CARE GRANTED IN  2007
This list includes patents granted in the United States. The list was retrieved by searching the claims section of all patent applications published. Salient search terms include skin care
active ingredients having properties such as anti-ageing, anti-wrinkle, antioxidant, acne control benefits, skin whitening or lightening, blemish removal, etc. This category includes technology
related to the synthesis and delivery of actives such as peptides, exfoliants, α-hydroxy acids, herbals, free radical scavengers, "green" derived molecules and compounds having unique
sensory properties.